Early-stage pancreatic cancer is characterized by IR and compensatory hyperinsulinemia, whereas advanced pancreatic cancer is characterized by a reduction in IR and insulin secretion to establish a new metabolic equilibrium. This evidence concerns the gene INS and familial pancreatic carcinoma.